Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

10rx vs Invyncible

10rx
Graded #199

Higher grade

vs+5.099999999999994
Invyncible
Graded #303

Lower grade

The verdict

10rx takes it — 66.1/100 to 61/100.

10rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 10rx is a nationwide GLP-1 telehealth program offering compounded weight-loss medication at low flat monthly rates: semaglutide at $99.67/month and tirzepatide at $149.67/month, with NAD+ and sermorelin…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost value10rx +26
81
55
Dose & formulationEven
64
64
Clinical oversightInvyncible +3
67
70
Labs & monitoringEven
52
52
FulfillmentInvyncible +3
62
65
Contract termsInvyncible +6
55
61
10rx · left barInvyncible · right bar

The numbers

Metric10rxInvyncible
WeighScore66.1/10061/100
GradeCC
Scorecard rank#199#303
Semaglutide$100/mo (compounded)$192/mo (0.5 mg dose, compounded)
Tirzepatide$150/mo (compounded)$210/mo (compounded)
CoverageCoverage not published40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
10rx

Graded #199 · C

Strengths

  • Very low pricing — compounded semaglutide $99.67/month and tirzepatide $149.67/month
  • Free online health quiz with board-certified telehealth doctors reviewing eligibility
  • Offers NAD+ and sermorelin alongside GLP-1, for energy and muscle recovery
  • Says it ships to all 50 states with discreet delivery from licensed pharmacy partners

Where it loses points

  • Doesn't publish its legal operating entity, so accountability is hard to verify
  • Pharmacy partners are described as licensed but none are named
  • No terms-of-service page is posted, and FAQ answers load only via script
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
  • No LegitScript or third-party accreditation is shown on the site
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard